The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The Lycopodium alkaloids
Abstract
Lycopodium alkaloids are quinolizine, or pyridine and alpha-pyridone type alkaloids. Some Lycopodium alkaloids are potent inhibitors of acetylcholinesterase (AChE). Huperzine A (HupA) is reported to increase efficiency for learning and memory in animals, and it shows promise in the treatment of Alzheimer's disease (AD). 201 Lycopodium alkaloids from 54 species of Lycopodium (sensu lato) have been reported so far. This review is intended to to cover the chemical, pharmacological and clinical research on Lycopodium alkaloids reported in the literature from the spring of 1993 to August 2004. Structures of 81 new Lycopodium alkaloids are presented, classified and analyzed. The structural characters and biogenetic relationships of the four major Lycopodium alkaloid groups (lycopodine, lycodine, fawcettimine and miscellaneous) are discussed. Bioactivities of Lycopodium alkaloids, especially HupA, are summarized. In particular, the effect of HupA and other cholinesterase inhibitors (anti-AD drugs) on acetylcholine esterase (AChE) activity in the rat cortex and butylcholine esterase activity are compared. Structure-activity relationships and structure modifications of HupA and its analogs are described. Information on clinical trials with HupA and its derivative ZT-1 is presented. The state of HupA availability and recent advances in in vitro propagation of HupA producing plants are outlined. Finally, hypotheses about Lycopodium alkaloid biosynthetic pathways are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity
Liu, J.-S., Zhu, Y.-L., Yu, C.-M., Zhou, Y.-Z., Han, Y.-Y., Wu, F.-W., & Qi, B.-F. (1986) · Canadian Journal of Chemistry · doi:10.1139/v86-137 · Cited by 473
The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam, M. (2004) · Learning & Memory · doi:10.1101/lm.69204 · Cited by 467
Sloane, P. D., Zimmerman, S., Suchindran, C., Reed, P., Wang, L., Boustani, M., & Sudha, S. (2002) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.23.100901.140525 · Cited by 461
Alzheimer’s disease pathogenesis and therapeutic interventions
Parihar, M. S., & Hemnani, T. (2004) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2003.12.007 · Cited by 433
Multigene Phylogeny of Land Plants with Special Reference to Bryophytes and the Earliest Land Plants
Nickrent, D. L., Parkinson, C. L., Palmer, J. D., & Duff, R. J. (2000) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026290 · Cited by 253
Matsunaga, T., Ishii, T., Matsumoto, S., Higuchi, M., Darvill, A., Albersheim, P., & O'Neill, M. A. (2004) · Plant Physiology · doi:10.1104/pp.103.030072 · Cited by 238
Xiao, X., Zhang, H., & Tang, X. C. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10075 · Cited by 155
Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat
Tang, X. C., Sarno, P. D., Sugaya, K., et al. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490240220 · Cited by 142
Clinical Pharmacokinetics of Galantamine
Farlow, M. R. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00005 · Cited by 134
Wang, R., Zhang, H., & Tang, X. C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01030-5 · Cited by 131
Wikström, N., & Kenrick, P. (2001) · Molecular Phylogenetics and Evolution · doi:10.1006/mpev.2001.0936 · Cited by 126
Ruberg, M., Rieger, F., Villageois, A. P., Bonnet, A. M., & Agid, Y. (1986) · Brain Research · doi:10.1016/0006-8993(86)91401-0 · Cited by 121
Jiang, H., Luo, X., & Bai, D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456747 · Cited by 106
Kozikowski, A. P., Campiani, G., Sun, L., et al. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9622822 · Cited by 106
Huperzine A and tacrine attenuate ?-amyloid peptide-induced oxidative injury
Xiao, X., Wang, R., & Tang, X. C. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000901)61:5<564::aid-jnr11>3.0.co;2-x · Cited by 101
Liang, Y. Q., & Tang, X. C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.071 · Cited by 96
Review of the Value of Huperzine as Pretreatment of Organophosphate Poisoning
Lallement, G., Baille, V., Baubichon, D., et al. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00015-3 · Cited by 89
Xiao, X., Wang, R., Han, Y., & Tang, X. C. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01088-0 · Cited by 85
Wang, T., & Tang, X. C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00199-x · Cited by 82
Huperzine-A in capsules and tablets for treating patients with Alzheimer disease.
Xu, S.-S., Cai, Z., Qu, Z., Yang, R., Cai, Y.-L., Wang, G.-Q., Xue-qian, S., Zhong, X.-S., Cheng, R.-Y., Xu, W.-A., et al. (1999) · PubMed · Cited by 81
Neotropical Lycopodiaceae-An Overview
Øllgaard, B. (1992) · Annals of the Missouri Botanical Garden · doi:10.2307/2399760 · Cited by 71
[Drug evaluation of huperzine A in the treatment of senile memory disorders].
ZHANG, R.-Q., Tang, X. C., Han, Y. Y., Sang, G.-W., Zhang, Y. D., X, Y., ZHANG, C.-W., & Yang, R. M. (1991) · PubMed · Cited by 69
Zhang, H., Yan, H., & Tang, X. C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.055 · Cited by 69
Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia ischemia
Wang, L. S., Zhou, J., Shao, X. M., & Tang, X. C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02977-3 · Cited by 65
Huperzine A (shuangyiping): a promising drug for Alzheimer's disease.
Tang, X. C. (1996) · PubMed · Cited by 64
McKinney, M., Miller, J. H., Yamada, F., Tückmantel, W., & Kozikowski, A. P. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90730-e · Cited by 62
Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
Wang, H., & Tang, X. C. (1998) · PubMed · Cited by 58
Tang, X.-C., Kindel, G. H., Kozikowski, A. P., & Hanin, I. (1994) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(94)01182-6 · Cited by 58
Ye, J. W., Cai, J. X., Wang, L. M., & Tang, X. C. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38024-3 · Cited by 58
Zhang, H., Liang, Y. Q., Tang, X. C., He, X., & Bai, D. L. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02437-5 · Cited by 56
Sun, Q. Q., Xu, S., Pan, J. L., Guo, H. M., & Cao, W. Q. (1999) · PubMed · Cited by 47
Zhang, J.-M., & Hu, G. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00206-8 · Cited by 45
Choline levels are increased in cerebrospinal fluid of Alzheimer patients
Elble, R. J., Giacobini, E., & Higgins, C. (1989) · Neurobiology of Aging · doi:10.1016/s0197-4580(89)80009-0 · Cited by 42
Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys
Ou, L. Y., Tang, X. C., & Cai, J. X. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01500-x · Cited by 37
Modulation of NMDA receptor by huperzine A in rat cerebral cortex.
Wang, X. D., Zhang, J., Yang, H., et al. (1999) · PubMed · Cited by 35
Ma, R., Jiang, S., & Zhu, D. (1998) · Biochemical Systematics and Ecology · doi:10.1016/s0305-1978(98)00022-2 · Cited by 32
CSF choline and acetylcholinesterase in early-onset vs. late-onset Alzheimer's disease patients
Kumar, V., Giacobini, E., & Markwell, S. J. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03910.x · Cited by 28
Extensive immunolesions of basal forebrain cholinergic system impair offspring recognition in sheep
Ferreira, G., Meurisse, M., Gervais, R., Ravel, N., & Lévy, F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00265-2 · Cited by 26
Alkaloids of Lycopodiumlucidulum Michx. Structure and properties of alkaloid L.23
Ayer, W. A., Altenkirk, B., Burnell, R. H., et al. (1969) · Canadian Journal of Chemistry · doi:10.1139/v69-065 · Cited by 24
Huperzine A ameliorates the impaired memory of aged rat in the Morris water maze performance.
Ye, J. W., Shang, Y., Wang, Z. M., et al. (2000) · PubMed · Cited by 22
Huperzine A reverses scopolamine- and muscimol-induced memory deficits in chick.
Gao, Y., Tang, X. C., Guan, L. C., et al. (2000) · PubMed · Cited by 16
Ros, E., Aleu, J., de Aranda, I. G., Muñoz‐Torrero, D., Camps, P., Badía, A., Marsal, J., & Solsona, C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01028-7 · Cited by 14
EFFECTS OF CHRONIC ADMINISTRATION OF HUPERZINE A ON MEMORY IN GUINEA PIGS
Filliat, P., Foquin, A., & Lallement, G. (2002) · Drug and Chemical Toxicology · doi:10.1081/dct-100108469 · Cited by 13
Cited by
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Arylglyoxals in Synthesis of Heterocyclic Compounds
Eftekhari-Sis, B., Zirak, M., & Akbari, A. (2013) · Chemical Reviews · doi:10.1021/cr300176g · Cited by 453
Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy
Murray, A., Faraoni, M., Castro, M., Alza, N., & Cavallaro, V. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040004 · Cited by 341
Huperzine A from Huperzia species—An ethnopharmacolgical review
Ma, X., Tan, C., Zhu, D., Gang, D. R., & Xiao, P. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.05.030 · Cited by 291
Self-citation
Metadata
- Authors
- Ma, X., & Gang, D. R.
- Venue
- Natural Product Reports
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2004
- Volume
- 21
- Issue
- 6
- Pages
- 752
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2340610485
- Cited by
- 649
- References
- 43
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.